The Board Meeting to be held on 22/05/2026 has been revised to 26/05/2026 The Board Meeting to be held on 22/05/2026 has been revised to 26/05/2026
MOREPENLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Morepen Laboratories has rescheduled its Board meeting from May 22, 2026 to May 26, 2026. The meeting was moved to accommodate an additional agenda item regarding consideration of a final dividend for FY 2025-26. The meeting will now cover two key items: (1) approval of audited standalone and consolidated financial results for Q4 and full year ended March 31, 2026, and (2) recommendation of a final dividend, if any. The trading window will remain closed until 48 hours after the results are made public on May 26, 2026.
This rescheduling with dividend consideration is a routine corporate event. Shareholders can expect Q4 and full-year FY26 results along with potential dividend news by May 26, 2026. The trading window closure is standard compliance and may temporarily limit insider trading activities.